Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-097496
Filing Date
2025-10-08
Accepted
2025-10-08 17:20:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 23305
  Complete submission text file 0001213900-25-097496.txt   25038
Mailing Address 16 HARTUM STREET RAD TOWER, 14TH FLOOR Har HaHotzvim Jerusalem L3 9777516
Business Address 16 HARTUM STREET RAD TOWER, 14TH FLOOR Har HaHotzvim Jerusalem L3 9777516 972 2 581-3140
Brainsway Ltd. (Subject) CIK: 0001505065 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90993 | Film No.: 251383156
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 320 NORTH SANGAMON STREET SUITE 1200 CHICAGO IL 60607
Business Address 320 NORTH SANGAMON STREET SUITE 1200 CHICAGO IL 60607 312-683-1900
Valor BrainsWay Holdings, LLC (Filed by) CIK: 0002044428 (see all company filings)

EIN.: 995148113
Type: SCHEDULE 13D/A